Michelle Aszterbaum

2.7k total citations
24 papers, 2.1k citations indexed

About

Michelle Aszterbaum is a scholar working on Molecular Biology, Dermatology and Genetics. According to data from OpenAlex, Michelle Aszterbaum has authored 24 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 10 papers in Dermatology and 10 papers in Genetics. Recurrent topics in Michelle Aszterbaum's work include Hedgehog Signaling Pathway Studies (17 papers), Cancer and Skin Lesions (8 papers) and Genetic and rare skin diseases. (8 papers). Michelle Aszterbaum is often cited by papers focused on Hedgehog Signaling Pathway Studies (17 papers), Cancer and Skin Lesions (8 papers) and Genetic and rare skin diseases. (8 papers). Michelle Aszterbaum collaborates with scholars based in United States and Poland. Michelle Aszterbaum's co-authors include Ervin H. Epstein, David R. Bickers, Jeannette M. Bonifas, Jean Y. Tang, Jingwu Xie, John H. Epstein, Vanja C. Douglas, Anthony E. Oro, Matthew P. Scott and Philip E. LeBoit and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

Michelle Aszterbaum

24 papers receiving 2.0k citations

Peers

Michelle Aszterbaum
Alan N. Moshell United States
Kye Yong Song South Korea
Kyung‐Cheol Sohn South Korea
Dean Ng United States
Alan N. Moshell United States
Michelle Aszterbaum
Citations per year, relative to Michelle Aszterbaum Michelle Aszterbaum (= 1×) peers Alan N. Moshell

Countries citing papers authored by Michelle Aszterbaum

Since Specialization
Citations

This map shows the geographic impact of Michelle Aszterbaum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michelle Aszterbaum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michelle Aszterbaum more than expected).

Fields of papers citing papers by Michelle Aszterbaum

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michelle Aszterbaum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michelle Aszterbaum. The network helps show where Michelle Aszterbaum may publish in the future.

Co-authorship network of co-authors of Michelle Aszterbaum

This figure shows the co-authorship network connecting the top 25 collaborators of Michelle Aszterbaum. A scholar is included among the top collaborators of Michelle Aszterbaum based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michelle Aszterbaum. Michelle Aszterbaum is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lentsch, Griffin, Bonnie Lee, Michelle Aszterbaum, et al.. (2022). Research Techniques Made Simple: Emerging Imaging Technologies for Noninvasive Optical Biopsy of Human Skin. Journal of Investigative Dermatology. 142(5). 1243–1252.e1. 27 indexed citations
2.
Tang, Jean Y., Mina S. Ally, Anita M. Chanana, et al.. (2016). Inhibition of the hedgehog pathway in patients with basal-cell nevus syndrome: final results from the multicentre, randomised, double-blind, placebo-controlled, phase 2 trial. The Lancet Oncology. 17(12). 1720–1731. 81 indexed citations
3.
Tang, Jean Y., Albert S. Chiou, Julian Mackay‐Wiggan, et al.. (2014). Tazarotene: Randomized, Double-Blind, Vehicle-Controlled, and Open-Label Concurrent Trials for Basal Cell Carcinoma Prevention and Therapy in Patients with Basal Cell Nevus Syndrome. Cancer Prevention Research. 7(3). 292–299. 25 indexed citations
4.
Tang, Jean Y., Julian Mackay‐Wiggan, Michelle Aszterbaum, et al.. (2012). Inhibiting the Hedgehog Pathway in Patients with the Basal-Cell Nevus Syndrome. New England Journal of Medicine. 366(23). 2180–2188. 383 indexed citations
5.
Tang, Jean Y., Michelle Aszterbaum, Mohammad Athar, et al.. (2010). Basal Cell Carcinoma Chemoprevention with Nonsteroidal Anti-inflammatory Drugs in Genetically Predisposed PTCH1 +/− Humans and Mice. Cancer Prevention Research. 3(1). 25–34. 61 indexed citations
6.
Tang, Jean Y., Angela Ruohao Wu, Eleni Linos, et al.. (2010). High Prevalence of Vitamin D Deficiency in Patients With Basal Cell Nevus Syndrome. Archives of Dermatology. 146(10). 1105–10. 24 indexed citations
7.
Langston, Alexander W., et al.. (2006). Long‐term establishment, characterization and manipulation of cell lines from mouse basal cell carcinoma tumors. Experimental Dermatology. 15(9). 742–750. 57 indexed citations
8.
So, Po-Lin, Kenneth Lee, Jennifer Hebert, et al.. (2004). Topical Tazarotene Chemoprevention Reduces Basal Cell Carcinoma Number and Size in Ptch1 +/− Mice Exposed to Ultraviolet or Ionizing Radiation. Cancer Research. 64(13). 4385–4389. 42 indexed citations
9.
Tang, Xiuwei, Arianna L. Kim, David J. Feith, et al.. (2004). Ornithine decarboxylase is a target for chemoprevention of basal and squamous cell carcinomas in Ptch1+/– mice. Journal of Clinical Investigation. 113(6). 867–875. 57 indexed citations
10.
Tang, Xiuwei, Arianna L. Kim, David J. Feith, et al.. (2004). Ornithine decarboxylase is a target for chemoprevention of basal and squamous cell carcinomas in Ptch1+/– mice. Journal of Clinical Investigation. 113(6). 867–875. 57 indexed citations
11.
Dellavalle, Robert P., Patrick Walsh, Angela Marchbank, et al.. (2002). CUSP/p63 expression in basal cell carcinoma. Experimental Dermatology. 11(3). 203–208. 15 indexed citations
12.
Athar, Mohammad, Kimberly D. Morel, Arianna L. Kim, et al.. (2001). Ultraviolet B (UVB)-Induced COX-2 Expression in Murine Skin: An Immunohistochemical Study. Biochemical and Biophysical Research Communications. 280(4). 1042–1047. 110 indexed citations
13.
Hebert, Jennifer, et al.. (2001). Chemoprevention of Basal Cell Carcinomas in the <i>ptc1<sup>+/–</sup></i> Mouse – Green and Black Tea. Skin Pharmacology and Physiology. 14(6). 358–362. 13 indexed citations
14.
Xie, Jingwu, Michelle Aszterbaum, Xiaoli Zhang, et al.. (2001). A role of PDGFRα in basal cell carcinoma proliferation. Proceedings of the National Academy of Sciences. 98(16). 9255–9259. 164 indexed citations
15.
Aszterbaum, Michelle, J.A. Beech, & Ervin H. Epstein. (1999). Ultraviolet Radiation Mutagenesis of Hedgehog Pathway Genes in Basal Cell Carcinomas. Journal of Investigative Dermatology Symposium Proceedings. 4(1). 41–45. 49 indexed citations
16.
Aszterbaum, Michelle, John H. Epstein, Anthony E. Oro, et al.. (1999). Ultraviolet and ionizing radiation enhance the growth of BCCs and trichoblastomas in patched heterozygous knockout mice. Nature Medicine. 5(11). 1285–1291. 317 indexed citations
17.
Aszterbaum, Michelle, et al.. (1998). Identification of Mutations in the Human PATCHED Gene in Sporadic Basal Cell Carcinomas and in Patients with the Basal Cell Nevus Syndrome. Journal of Investigative Dermatology. 110(6). 885–888. 223 indexed citations
18.
Williams, Mary L., et al.. (1993). Preservation of Permeability Barrier Ontogenesis in the Intrauterine Growth-Retarded Fetal Rat. Pediatric Research. 33(4). 418–424. 13 indexed citations
19.
Aszterbaum, Michelle, Kenneth R. Feingold, Gopinathan K. Menon, & Mary L. Williams. (1993). Glucocorticoids accelerate fetal maturation of the epidermal permeability barrier in the rat.. Journal of Clinical Investigation. 91(6). 2703–2708. 62 indexed citations
20.
Aszterbaum, Michelle, Gopinathan K. Menon, Kenneth R. Feingold, & Mary L. Williams. (1992). Ontogeny of the Epidermal Barrier to Water Loss in the Rat: Correlation of Function with Stratum Corneum Structure and Lipid Content. Pediatric Research. 31(4). 308–317. 74 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026